The subject of the order is the delivery for pharmacy of medicinal products, medical devices, biocidal products, cosmetics, raw materials for the recipe, small molecule derivatives of heparin, special purpose foods. A detailed description of the subject of the contract shall include a model of the contract, together with an annex (assortment specification — quantitative — price), which is Annex 3 to SWZ. Address of the website where changes and explanations of SWZ content and other contract documents directly related to the procurement procedure will be made available: https://www.kcr.pl/zamowienia-publiczne-2021/ - 'website of the proceed'. The public contract shall be awarded in accordance with the Law of 11 September 2019 — Public Procurement Law by unrestricted tender, using the so-called 'reverse procedure' described in Article 139 Pzp. A vadium in the proceedings is not required.

Part 1/ Medicinal products of various therapeutic groups; A detailed description of the subject of the contract shall include a model of the contract, together with an annex (assortment specification — quantitative — price), which is Annex 3 to SWZ. SWZ records should be read along with any changes to SWZ content, which are, for example, the result of answers to Contractors' inquiries.

Part 10/ Medicinal products of various therapeutic groups, raw materials for recipes, medical devices, special purpose foodstuffs. A detailed description of the subject of the contract shall include a model of the contract, together with an annex (assortment specification — quantitative — price), which is Annex 3 to SWZ. SWZ records should be read along with any changes to SWZ content, which are, for example, the result of answers to Contractors' inquiries.

Part 11/ Minor Molecular Heparin Derivatives. A detailed description of the subject of the contract shall include a model of the contract, together with an annex (assortment specification — quantitative — price), which is Annex 3 to SWZ. SWZ records should be read along with any changes to SWZ content, which are, for example, the result of answers to Contractors' inquiries.

Part 12/ Minor Molecular Heparin Derivatives. A detailed description of the subject of the contract shall include a model of the contract, together with an annex (assortment specification — quantitative — price), which is Annex 3 to SWZ. SWZ records should be read along with any changes to SWZ content, which are, for example, the result of answers to Contractors' inquiries.

Part 13/ Medicinal products, medical devices, biocidal products. A detailed description of the subject of the contract shall include a model of the contract, together with an annex (assortment specification — quantitative — price), which is Annex 3 to SWZ. SWZ records should be read along with any changes to SWZ content, which are, for example, the result of answers to Contractors' inquiries.

Part 14/ Medicinal products, medical devices, biocidal products. A detailed description of the subject of the contract shall include a model of the contract, together with an annex (assortment specification — quantitative — price), which is Annex 3 to SWZ. SWZ records should be read along with any changes to SWZ content, which are, for example, the result of answers to Contractors' inquiries.

Part 15/ Medicinal products, medical devices, biocidal products. A detailed description of the subject of the contract shall include a model of the contract, together with an annex (assortment specification — quantitative — price), which is Annex 3 to SWZ. SWZ records should be read along with any changes to SWZ content, which are, for example, the result of answers to Contractors' inquiries.

Part 16/ Medicinal products. A detailed description of the subject of the contract shall include a model of the contract, together with an annex (assortment specification — quantitative — price), which is Annex 3 to SWZ. SWZ records should be read along with any changes to SWZ content, which are, for example, the result of answers to Contractors' inquiries.

Part 17/ Medicinal products, medical devices, biocidal products. A detailed description of the subject of the contract shall include a model of the contract, together with an annex (assortment specification — quantitative — price), which is Annex 3 to SWZ. SWZ records should be read along with any changes to SWZ content, which are, for example, the result of answers to Contractors' inquiries.

Part 18/ Medicinal products of various therapeutic groups. A detailed description of the subject of the contract shall include a model of the contract, together with an annex (assortment specification — quantitative — price), which is Annex 3 to SWZ. SWZ records should be read along with any changes to SWZ content, which are, for example, the result of answers to Contractors' inquiries.

Part 19/ Medicinal products of various therapeutic groups. A detailed description of the subject of the contract shall include a model of the contract, together with an annex (assortment specification — quantitative — price), which is Annex 3 to SWZ. SWZ records should be read along with any changes to SWZ content, which are, for example, the result of answers to Contractors' inquiries.

Part 2/ Medicinal products of various therapeutic groups. A detailed description of the subject of the contract shall include a model of the contract, together with an annex (assortment specification — quantitative — price), which is Annex 3 to SWZ. SWZ records should be read along with any changes to SWZ content, which are, for example, the result of answers to Contractors' inquiries.

Part 20/ Medicinal products, medical devices, biocidal products and cosmetics. A detailed description of the subject of the contract shall include a model of the contract, together with an annex (assortment specification — quantitative — price), which is Annex 3 to SWZ. SWZ records should be read along with any changes to SWZ content, which are, for example, the result of answers to Contractors' inquiries.

Part 21/ Seams, including: task A - Unabsorbed seam — synthetic monofilament, non-absorbable, made of polyamide polymer, dyed, easy to manipulate and bond; task B - Non-absorbable seam - synthetic braided polyester coated with silicone; task C - Non-absorbable suture - synthetic plaited uncoated polyester; task D - bone wax, for Hemostasis, with bone bleeding in the form of flakes; task E - absorbed seams - braided made of copolymer 90% glycolide and 10% L-lactide copolymer copolymer and calcium stearate. Tissue support period after 14 days after implantation above 70% of initial support strength, with total suture absorption period of up to 70 days; Task F absorbed seams — Synthetic monofilament with long absorption period (180 — 210 days) and prolonged maintenance period Tissue, after 28 days above 50% of the initial strength of tissue support; task G - absorbed sutures - braided copolymer with 90% glycolide and 10% L-lactide copolymer copolymer and calcium stearate. The period of tissue support after 14 days after implantation above 70% of the initial. A detailed description of the subject of the contract shall include a model of the contract, together with an annex (assortment specification — quantitative — price), which is Annex 3 to SWZ. SWZ records should be read along with any changes to SWZ content, which are, for example, the result of answers to Contractors' inquiries.

Part 3/ Medicinal products of various therapeutic groups. A detailed description of the subject of the contract shall include a model of the contract, together with an annex (assortment specification — quantitative — price), which is Annex 3 to SWZ. SWZ records should be read along with any changes to SWZ content, which are, for example, the result of answers to Contractors' inquiries.

Part 4/ Medicinal products of various therapeutic groups. A detailed description of the subject of the contract shall include a model of the contract, together with an annex (assortment specification — quantitative — price), which is Annex 3 to SWZ. SWZ records should be read along with any changes to SWZ content, which are, for example, the result of answers to Contractors' inquiries.

Part 5/ Medicinal products, medical devices. A detailed description of the subject of the contract shall include a model of the contract, together with an annex (assortment specification — quantitative — price), which is Annex 3 to SWZ. SWZ records should be read along with any changes to SWZ content, which are, for example, the result of answers to Contractors' inquiries.

Part 6/ Medicinal products, medical devices. A detailed description of the subject of the contract shall include a model of the contract, together with an annex (assortment specification — quantitative — price), which is Annex 3 to SWZ. SWZ records should be read along with any changes to SWZ content, which are, for example, the result of answers to Contractors' inquiries.

Part 7/ Medicinal products of various therapeutic groups. A detailed description of the subject of the contract shall include a model of the contract, together with an annex (assortment specification — quantitative — price), which is Annex 3 to SWZ. SWZ records should be read along with any changes to SWZ content, which are, for example, the result of answers to Contractors' inquiries.

Part 8/ Minor Molecular Heparin Derivatives and Medicinal Products of Different Therapeutic Groups. A detailed description of the subject of the contract shall include a model of the contract, together with an annex (assortment specification — quantitative — price), which is Annex 3 to SWZ. SWZ records should be read along with any changes to SWZ content, which are, for example, the result of answers to Contractors' inquiries.

Part 9/ Medicinal products of various therapeutic groups. A detailed description of the subject of the contract shall include a model of the contract, together with an annex (assortment specification — quantitative — price), which is Annex 3 to SWZ. SWZ records should be read along with any changes to SWZ content, which are, for example, the result of answers to Contractors' inquiries.